Transcription of Unique Device Identification (UDI) system… should ...
{{id}} {{{paragraph}}}
BaltimoreJune 2017A Regulation of the European Parliament and of the Council on [/in vitrodiagnostic] medical devices (approved by EP on 5 April 2017; published 5 May 2017 in the Official Journal of the EU; date of application 26 May 2020):Whereas: (41/38) The traceability of devicesby means of a Unique Device Identification (UDI) should significantly enhance the effectiveness of the post-market safety-related activitiesfor devices, which is owing to improved incident reporting, targeted field safety corrective actionsand better monitoring by competent authorities.
Baltimore June 2017 Presented by: Jay Crowley. VP of UDI Services and Solutions. USDM Life Sciences. jcrowley@usdm.com. The EU MDR and IVDR UDI Requirements
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Title: Post-Marketing Surveillance (PMS) post, Post, Market Safety and Quality, Market Safety and Quality Management, MEDICAL DEVICE REGULATION PRE-MARKET, MEDICAL DEVICE REGULATION PRE-MARKET APPROVAL, Target Product Profile, Market Commitment (AMC) for Pneumococcal Conjugate, GUIDELINES FOR MONITORING AND REPORTING, Developing Budgets for Research Projects